CAS 915087-24-0

2-fluoro-N-methyl-4-nitrobenzamide

Codes: ENZA-003

Application context (from source-drug indications)

Hormone-sensitive prostate cancerEnzalutamideCastration-resistant prostate cancerEnzalutamideProstate cancerEnzalutamide

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Enzalutamide	Tier A — Act now	2027

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

EnzalutamideOriginator routesteps: 5total yield: 15 mg

2-fluoro-1-methyl-4-nitrobenzene→2-fluoro-4-nitrobenzoic acid→2-fluoro-N-methyl-4-nitrobenzamide→4-amino-2-fluoro-N-methylbenzamide→2-hydroxy-2-methylpropanenitrile→4-((2-cyanopropan-2-yl)amino)-2-fluoro-N-methylbenzamide→4-isothiocyanato-2-(trifluoromethyl)benzonitrile

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.